Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Frontiers in Pharmacology | journal | 1.384 Q1 | 154 | 2200 | 3969 | 145595 | 22327 | 3901 | 5.45 | 66.18 |  |
| 2 | Vaccines | journal | 1.296 Q1 | 85 | 782 | 345 | 49214 | 1510 | 334 | 4.18 | 62.93 | |
| 3 | Advances in Therapy | journal | 1.097 Q1 | 83 | 371 | 657 | 14983 | 2705 | 624 | 3.49 | 40.39 | |
| 4 | Antibiotics | journal | 0.960 Q2 | 77 | 928 | 416 | 54250 | 1995 | 408 | 4.60 | 58.46 | |
| 5 | Inflammopharmacology | journal | 0.945 Q2 | 68 | 122 | 303 | 7731 | 1325 | 302 | 4.13 | 63.37 | |
| 6 | PharmacoEconomics - Open | journal | 0.637 Q2 | 20 | 65 | 135 | 2345 | 263 | 120 | 1.82 | 36.08 | |
| 7 | Cardiology | journal | 0.547 Q3 | 72 | 115 | 349 | 3031 | 430 | 267 | 1.09 | 26.36 | |
| 8 | Chemotherapy | journal | 0.539 Q3 | 61 | 29 | 114 | 882 | 236 | 111 | 2.36 | 30.41 | |
| 9 | Drugs - Real World Outcomes | journal | 0.430 Q3 | 21 | 40 | 69 | 1228 | 125 | 67 | 1.88 | 30.70 | |
| 10 | WHO Drug Information | journal | 0.167 Q4 | 11 | 10 | 29 | 202 | 5 | 24 | 0.06 | 20.20 | |
| 11 | Pharma-Kritik (discontinued) | journal | 0.101 Q4 | 2 | 9 | 57 | 66 | 0 | 37 | 0.00 | 7.33 | |
| 12 | EJNMMI Radiopharmacy and Chemistry | journal | 28 | 31 | 61 | 1242 | 189 | 55 | 3.18 | 40.06 | | |
| 13 | Frontiers in Medical Technology | journal | 15 | 29 | 3 | 2497 | 2 | 0 | 0.67 | 86.10 | | |
| 14 | Journal of Cardiovascular Development and Disease | journal | 32 | 59 | 122 | 4208 | 436 | 118 | 3.65 | 71.32 | | |
| 15 | Medical Cannabis and Cannabinoids | journal | 13 | 10 | 25 | 384 | 53 | 21 | 2.12 | 38.40 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data